The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...

YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...

The Zika virus modifies the chemical composition of human skin, making individuals more attractive to mosquitoes. These ...

Assistant Professor in the School of Biological Science and Medical Engineering at Beihang University. She received her Ph.D.

Dr MKO AbimbolaDiabetes is a long-term condition caused by defi­ciency in quantity or function of insulin, the chemical controlling the level of sugar in the blood. People with diabetes par­ticularly ...

Joint health is a critical aspect of overall wellness that is often overlooked until discomfort arises. As we age, the wear ...

A study has elucidated the mechanism by which bacterial cellulose mediates plant tissue regeneration. The work has been ...

The skin serves as the body's primary defense against harmful microorganisms, toxins, and physical damage. However, severe ...

New research could transform how broken bones are treated, with the development of a special zinc-based dissolvable material that could replace the metal plates and screws typically used to hold ...

Recent research into bacterial cellulose patches may speed plants' recovery, improve grafting and help with preservation.